Skip to main content
Top
Published in: Rheumatology International 2/2013

01-02-2013 | Original Article

TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren’s syndrome patients

Authors: Hideki Nakamura, Yoshiro Horai, Takahisa Suzuki, Akitomo Okada, Kunihiro Ichinose, Satoshi Yamasaki, Takehiko Koji, Atsushi Kawakami

Published in: Rheumatology International | Issue 2/2013

Login to get access

Abstract

This study aimed at ascertain whether innate immunity is involved in the apoptosis of primary cultured salivary gland epithelial cells (SGECs) in primary Sjögren’s syndrome (pSS). Induction of apoptosis of SGECs was performed using a TLR3 ligand, poly (I:C). Activation of phosphorylated-Akt (pAkt) and cleaved-caspase 3 was determined by Western blotting or immunofluorescence. Expression of TLR2 and TLR3 with pAkt was observed in cultured SGECs after 24-h stimulation with each ligand. Compared with stimulation with the peptidoglycan or lipopolysaccharide, that with poly (I:C) induced significant nuclear fragmentation, as determined by Hoechst staining (p = 0.0098). Apoptosis was confirmed by terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL) staining of SGECs from pSS patients and a normal subject. A significant increase in TUNEL-positive cells was observed by the addition of a PI3K inhibitor, LY294002. Poly (I:C) phosphorylated stress-activated protein kinase/Jun-terminal kinase and p44/42 MAP kinase as well as Akt. Furthermore, poly (I:C)-induced caspase 3 cleavage in SGECs was also inhibited by LY294002. Similar results were obtained using SGECs obtained from a normal subject. The results demonstrated for the first time that TLR3 induces the apoptotic cell death of SGECs via the PI3K-Akt signaling pathway.
Literature
1.
go back to reference Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373–384PubMedCrossRef Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11:373–384PubMedCrossRef
3.
4.
go back to reference Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, Fujikawa K et al (2007) Toll-like receptor in salivary glands from patients with Sjögren’s syndrome: functional analysis by human salivary gland cell line. J Rheumatol 34:1019–1026PubMed Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, Fujikawa K et al (2007) Toll-like receptor in salivary glands from patients with Sjögren’s syndrome: functional analysis by human salivary gland cell line. J Rheumatol 34:1019–1026PubMed
6.
go back to reference Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren’s syndrome. Transl Res 148:281–288PubMedCrossRef Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren’s syndrome. Transl Res 148:281–288PubMedCrossRef
7.
go back to reference Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K (2007) Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with primary Sjögren’s syndrome. Clin Exp Rheumatol 25:831–837PubMed Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K (2007) Epidermal growth factor inhibits Fas-mediated apoptosis in salivary epithelial cells of patients with primary Sjögren’s syndrome. Clin Exp Rheumatol 25:831–837PubMed
8.
go back to reference Nakamura H, Kawakami A, Iwamoto N, Ida H, Koji T, Eguchi K (2008) Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sjögren’s syndrome. Apoptosis 13:1322–1330PubMedCrossRef Nakamura H, Kawakami A, Iwamoto N, Ida H, Koji T, Eguchi K (2008) Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sjögren’s syndrome. Apoptosis 13:1322–1330PubMedCrossRef
9.
go back to reference Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T (2006) TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176:4894–4901PubMed Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T (2006) TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176:4894–4901PubMed
10.
go back to reference Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E, Giladi H (2007) TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100:1301–1312PubMedCrossRef Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E, Giladi H (2007) TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100:1301–1312PubMedCrossRef
11.
go back to reference Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRef
12.
go back to reference Nakamura H, Kawakami A, Iwamoto N, Okada A, Yamasaki S, Tamai M et al (2010) A single centre retrospective analysis of AECG classification criteria for primary Sjogren’s syndrome based on 112 minor salivary gland biopsies in a Japanese population. Rheumatology (Oxford) 49:1290–1293CrossRef Nakamura H, Kawakami A, Iwamoto N, Okada A, Yamasaki S, Tamai M et al (2010) A single centre retrospective analysis of AECG classification criteria for primary Sjogren’s syndrome based on 112 minor salivary gland biopsies in a Japanese population. Rheumatology (Oxford) 49:1290–1293CrossRef
13.
go back to reference Nakamura H, Koji T, Tominaga M et al (1998) Apoptosis in labial salivary glands from Sjögren’s syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients. Clin Exp Immunol 114:106–112PubMedCrossRef Nakamura H, Koji T, Tominaga M et al (1998) Apoptosis in labial salivary glands from Sjögren’s syndrome (SS) patients: comparison with human T lymphotropic virus-I (HTLV-I)-seronegative and -seropositive SS patients. Clin Exp Immunol 114:106–112PubMedCrossRef
14.
go back to reference Nakamura H, Kawakami A, Hayashi T, Iwamoto N, Okada A, Tamai M et al (2010) Anti-centromere antibody-seropositive Sjögren’s syndrome differs from conventional subgroup in clinical and pathological study. BMC Musculoskelet Disord 11:140PubMedCrossRef Nakamura H, Kawakami A, Hayashi T, Iwamoto N, Okada A, Tamai M et al (2010) Anti-centromere antibody-seropositive Sjögren’s syndrome differs from conventional subgroup in clinical and pathological study. BMC Musculoskelet Disord 11:140PubMedCrossRef
15.
go back to reference Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ et al (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428(6980):341–345PubMedCrossRef Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ et al (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428(6980):341–345PubMedCrossRef
16.
go back to reference Liew FY, Xu D, Brint EK, O’Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446–458PubMedCrossRef Liew FY, Xu D, Brint EK, O’Neill LA (2005) Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 5:446–458PubMedCrossRef
17.
go back to reference Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H et al (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301(5633):640–643PubMedCrossRef Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H et al (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301(5633):640–643PubMedCrossRef
18.
go back to reference Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M et al (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5:503–507PubMedCrossRef Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M et al (2004) RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat Immunol 5:503–507PubMedCrossRef
19.
go back to reference Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC (2004) Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11:1060–1067PubMedCrossRef Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, Sen GC (2004) Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11:1060–1067PubMedCrossRef
20.
go back to reference Kong L, Ogawa N, Nakabayashi T et al (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren’s syndrome. Arthritis Rheum 40:87–97PubMedCrossRef Kong L, Ogawa N, Nakabayashi T et al (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren’s syndrome. Arthritis Rheum 40:87–97PubMedCrossRef
21.
go back to reference Matsumura R, Umemiya K, Kagami M et al (1998) Glandular and extraglandular expression of the Fas–Fas ligand and apoptosis in patients with Sjögren’s syndrome. Clin Exp Rheumatol 16:561–568PubMed Matsumura R, Umemiya K, Kagami M et al (1998) Glandular and extraglandular expression of the Fas–Fas ligand and apoptosis in patients with Sjögren’s syndrome. Clin Exp Rheumatol 16:561–568PubMed
22.
go back to reference Ohlsson M, Skarstein K, Bolstad AI, Johannessen AC, Jonsson R (2001) Fas-induced apoptosis is a rare event in Sjögren’s syndrome. Lab Invest 81:95–105PubMedCrossRef Ohlsson M, Skarstein K, Bolstad AI, Johannessen AC, Jonsson R (2001) Fas-induced apoptosis is a rare event in Sjögren’s syndrome. Lab Invest 81:95–105PubMedCrossRef
23.
go back to reference Tsubota K, Saito I, Miyasaka N (1994) Expression of granzyme A and perforin in lacrimal gland of Sjögren’s syndrome. Adv Exp Med Biol 1350:637–640CrossRef Tsubota K, Saito I, Miyasaka N (1994) Expression of granzyme A and perforin in lacrimal gland of Sjögren’s syndrome. Adv Exp Med Biol 1350:637–640CrossRef
24.
go back to reference Kolkowski EC, Reth P, Pelusa F, Bosch J, Pujol-Borrell R, Coll J et al (1999) Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren’s syndrome. J Autoimmun 13:155–162PubMedCrossRef Kolkowski EC, Reth P, Pelusa F, Bosch J, Pujol-Borrell R, Coll J et al (1999) Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren’s syndrome. J Autoimmun 13:155–162PubMedCrossRef
25.
go back to reference Manoussakis MN, Spachidou MP, Maratheftis CI (2010) Salivary epithelial cells from Sjogren’s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 35:212–218PubMedCrossRef Manoussakis MN, Spachidou MP, Maratheftis CI (2010) Salivary epithelial cells from Sjogren’s syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 35:212–218PubMedCrossRef
26.
go back to reference Numata T, Araya J, Fujii S, Hara H, Takasaka N, Kojima J et al (2011) Insulin-dependent phosphatidylinositol 3-kinase/Akt and ERK signaling pathways inhibit TLR3-mediated human bronchial epithelial cell apoptosis. J Immunol 187:510–519PubMedCrossRef Numata T, Araya J, Fujii S, Hara H, Takasaka N, Kojima J et al (2011) Insulin-dependent phosphatidylinositol 3-kinase/Akt and ERK signaling pathways inhibit TLR3-mediated human bronchial epithelial cell apoptosis. J Immunol 187:510–519PubMedCrossRef
27.
go back to reference Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA et al (2006) Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459–8464PubMedCrossRef Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA et al (2006) Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci USA 103:8459–8464PubMedCrossRef
28.
go back to reference Liu Y, Kimura K, Yanai R, Chikama T, Nishida T (2008) Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C). Invest Ophthalmol Vis Sci 49:3336–3344PubMedCrossRef Liu Y, Kimura K, Yanai R, Chikama T, Nishida T (2008) Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C). Invest Ophthalmol Vis Sci 49:3336–3344PubMedCrossRef
Metadata
Title
TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren’s syndrome patients
Authors
Hideki Nakamura
Yoshiro Horai
Takahisa Suzuki
Akitomo Okada
Kunihiro Ichinose
Satoshi Yamasaki
Takehiko Koji
Atsushi Kawakami
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2381-9

Other articles of this Issue 2/2013

Rheumatology International 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.